Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation
Clinical trial NCT06865352 · COMPLETED
Trial details
- NCT number
- NCT06865352
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-13
- Primary completion
- 2025-01-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.